﻿<?xml version="1.0" encoding="utf-8"?><rss version="2.0" xmlns:media="http://search.yahoo.com/mrss/"><channel><title>Cision News</title><link>https://news.cision.com</link><description>Cision is the leading global provider of media research, distribution, monitoring and evaluation services. With over 40 locations throughout the world, Cision provides the insight, expertise and intelligence that improve performance and build reputations.</description><pubDate>Tue, 09 Jun 2026 15:46:41 GMT</pubDate><image><title>Cision News</title><width>146</width><height>60</height><link>https://news.cision.com</link><url>https://news.cision.com/Content/img/news-logo.png</url></image><item><title>ContextVision AB: Q2 interim report 2025 – Customers pressured by trade uncertainty – We continue to invest to build tomorrow’s solutions</title><link>https://news.cision.com/contextvision-ab/r/contextvision-ab--q2-interim-report-2025---customers-pressured-by-trade-uncertainty---we-continue-to,c4222803</link><guid isPermaLink="false">cision5196963</guid><description><![CDATA[Q2 Highlights

  · Parterships signed with the University of Waterloo and ultrasound technology expert InPhase Solutions AS to advance ultrasound diagnostics for MASLD
  · Partnership signed with AMRA Medical to enable correlations between MRI and ultrasound imaging biomarkers
  · Attended the CMEF Conference in Shanghai with further discussions with potential customers
  · New customer signed in Asia within Specialty ultrasound
  · Released a Rivent upgrade with improved performance, and completed the development of a platform that will lead to a new line of products that are]]></description><pubDate>Tue, 26 Aug 2025 06:00:00 GMT</pubDate></item><item><title>ContextVision publishes Webcast for the Q2 report 2025</title><link>https://news.cision.com/contextvision-ab/r/contextvision-publishes-webcast-for-the-q2-report-2025,c4222819</link><guid isPermaLink="false">cision5196968</guid><description><![CDATA[Watch CEO Gerald Pötzsch and CFO Richard Hallström present ContextVision’s highlights from Q2 2025 along with the financials for the quarter.

The Webcast is available on ContextVision’s website following the link below: 
https://www.contextvision.se/webcast/

For more details, contact ContextVision’s CFO, Richard Hallström at richard.hallstrom@contextvision.com or visit our official website at www.contextvision.com.
 

About ContextVision
ContextVision is a software company specialized in image analysis and artificial intelligence. As the global market leader within image]]></description><pubDate>Tue, 26 Aug 2025 06:00:00 GMT</pubDate></item><item><title>ContextVision and AMRA Medical join forces to advance multimodal imaging in liver disease diagnostics</title><link>https://news.cision.com/contextvision-ab/r/contextvision-and-amra-medical-join-forces-to-advance-multimodal-imaging-in-liver-disease-diagnostic,c4156393</link><guid isPermaLink="false">cision5062371</guid><description><![CDATA[ContextVision, a global leader in medical imaging software, and AMRA Medical (Sweden), a pioneer in magnetic resonance imaging (MRI) based body composition analysis, today announce a research partnership focused on advancing the diagnosis of metabolic dysfunction-associated steatotic liver disease (MASLD).
The collaboration expands upon ContextVision’s ongoing Data Quality initiative to develop AI-powered, organ-specific imaging solutions that enable MASLD screening and physiological quantification. The joint effort builds on ContextVision’s strategic clinical partnership with the University]]></description><pubDate>Fri, 30 May 2025 06:00:00 GMT</pubDate></item><item><title>BULLETIN FROM THE ANNUAL GENERAL MEETING OF CONTEXTVISION AB (PUBL)</title><link>https://news.cision.com/contextvision-ab/r/bulletin-from-the-annual-general-meeting-of-contextvision-ab--publ-,c4149806</link><guid isPermaLink="false">cision5051832</guid><description><![CDATA[At the annual general meeting of ContextVision AB (publ) held on May 13, 2025, the following decisions were made:

Adoption of the income statement and the balance sheet

The general meeting resolved to adopt the income statement and the balance sheet as well as the consolidated income statement and the consolidated balance sheet.

Dividend

The general meeting resolved that no dividend shall be distributed for the financial year 2024 and that the company’s result shall be carried forward in the new accounts.

Discharge from liability

The general meeting resolved to discharge]]></description><pubDate>Tue, 13 May 2025 13:45:00 GMT</pubDate></item><item><title>ContextVision AB: Q1 interim report 2025 – Executing on our strategy for Image Quality and Data Quality</title><link>https://news.cision.com/contextvision-ab/r/contextvision-ab--q1-interim-report-2025---executing-on-our-strategy-for-image-quality-and-data-qual,c4146194</link><guid isPermaLink="false">cision5047066</guid><description><![CDATA[Q1 highlights

  · Partnership signed with the University of Washington as we progress our aim to develop organ-specific digital biomarkers
  · Investments in ultrasound equipment to support our clinical research in the U.S.
  · Attended the ECR Conference with high interest from current and potential customers
  · Fruitful collaborations with customers to support a larger part of the image processing chain

Q1 Financial Data

  · Revenue of 26.3 MSEK (34.7) , down 24,2%.
  · EBITDA amounted to -1.6 MSEK (12.8) with an EBITDA margin of -6.3% (36.9).
  · Adjusted EBITDA amounted]]></description><pubDate>Wed, 07 May 2025 06:00:00 GMT</pubDate></item><item><title>ContextVision publishes Webcast for the Q1 report 2025</title><link>https://news.cision.com/contextvision-ab/r/contextvision-publishes-webcast-for-the-q1-report-2025,c4146203</link><guid isPermaLink="false">cision5047068</guid><description><![CDATA[Watch CEO Gerald Pötzsch and CFO Richard Hallström present ContextVision’s highlights from Q1 2025 along with the financials for the quarter.

The Webcast is available on ContextVision’s website following the link below:
https://www.contextvision.se/webcast/

For more details, contact ContextVision’s CFO, Richard Hallström at richard.hallstrom@contextvision.com or visit our official website at www.contextvision.com.

About ContextVision
ContextVision is a software company specialized in image analysis and artificial intelligence. As the global market leader within image enhancement,]]></description><pubDate>Wed, 07 May 2025 06:00:00 GMT</pubDate></item><item><title>ContextVision publishes annual report for the fiscal year 2024</title><link>https://news.cision.com/contextvision-ab/r/contextvision-publishes-annual-report-for-the-fiscal-year-2024,c4134415</link><guid isPermaLink="false">cision5030336</guid><description><![CDATA[The annual report of ContextVision for the fiscal year 2024 is now available at www.contextvision.com.

The annual report is a summary of the past year as well as an overview of the company's development and progress.

The annual report is available in both Swedish and English versions. The report is best suited for reading on screen. Printed copies can be ordered via ir@contextvision.com

ContextVision also registers the ESEF version (European Single Electronic Format) of the annual report for 2024 with the Swedish Financial Supervisory Authority.

For more information, please]]></description><pubDate>Fri, 11 Apr 2025 07:30:00 GMT</pubDate></item><item><title>NOTICE TO THE ANNUAL GENERAL MEETING IN CONTEXTVISION AB (PUBL)</title><link>https://news.cision.com/contextvision-ab/r/notice-to-the-annual-general-meeting-in-contextvision-ab--publ-,c4134751</link><guid isPermaLink="false">cision5030351</guid><description><![CDATA[The shareholders of ContextVision AB (publ), reg. no. 556377-8900, are hereby invited to the Annual General Meeting on Tuesday, 13 May 2025, at 14:00, at the company's premises, Gamla Brogatan 26, Stockholm.

Participation and Notification etc

Shareholders who wish to participate in the general meeting with the right to vote shall

  · be recorded as shareholder in the share register kept by Euroclear Sweden AB on Monday, 5 May 2025, temporary registration for shareholders registered at Norska Verdipapirsentralen (VPS) is made through DNB Bank ASA, see below; and

  · give notice]]></description><pubDate>Fri, 11 Apr 2025 07:30:00 GMT</pubDate></item><item><title>ContextVision partners with University of Waterloo in Canada and InPhase Solutions AS in Norway to advance ultrasound diagnostics for MASLD</title><link>https://news.cision.com/contextvision-ab/r/contextvision-partners-with-university-of-waterloo-in-canada-and-inphase-solutions-as-in-norway-to-a,c4131209</link><guid isPermaLink="false">cision5025589</guid><description><![CDATA[ContextVision, a global leader in medical imaging solutions, is strengthening its research ecosystem by establishing key partnerships with ultrasound data scientists and clinical experts. These collaborations will accelerate the development of ContextVision’s AI-based solutions capable of interpreting organ-specific ultrasound imaging datasets, with a first focus on optimizing data quality for the diagnosis of metabolic dysfunction-associated steatotic liver disease (MASLD).
As part of this initiative, ContextVision has signed a research agreement with the University of Waterloo’s Laboratory]]></description><pubDate>Mon, 07 Apr 2025 06:00:00 GMT</pubDate></item><item><title>ContextVision AB: Year-end Report 2024 – Progress in Data Quality and growing interest</title><link>https://news.cision.com/contextvision-ab/r/contextvision-ab--year-end-report-2024---progress-in-data-quality-and-growing-interest,c4108398</link><guid isPermaLink="false">cision4993020</guid><description><![CDATA[Q4 highlights

  · Attended the RSNA Conference in Chicago and launched two products.
  · Ongoing discussions about collaborations with key customers, including tier 1 OEMs.
  · Strong interest in the industry regarding quantitative imaging – reinforcing our strategy.
  · Continued progress within Data Quality – now conducting tests, measurements and experiments.
  · Share buy-back of approximately 1.2 million shares at a price of 6.50 NOK per share.

Q4 Financial Data

  · Revenue of 34.1 MSEK (33.2), up 2.8%.
  · EBITDA amounted to 9.1 MSEK (5.2) with an EBITDA margin of 26.8% (]]></description><pubDate>Thu, 20 Feb 2025 07:00:00 GMT</pubDate></item><item><title>ContextVision publishes Webcast for the Year-end Report 2024</title><link>https://news.cision.com/contextvision-ab/r/contextvision-publishes-webcast-for-the-year-end-report-2024,c4108426</link><guid isPermaLink="false">cision4993022</guid><description><![CDATA[Watch CEO Gerald Pötzsch and CFO Richard Hallström present ContextVision’s highlights from Q4 2024 along with the financials for the quarter and full year.

The Webcast is available on ContextVision’s website following the link below:

https://www.contextvision.se/webcast/ (https://www.contextvision.com/investors/webcast/) 

For more details, contact ContextVision’s CFO, Richard Hallström at richard.hallstrom@contextvision.com or visit our official website at www.contextvision.com.

About ContextVision
ContextVision is a medical technology software company specialized in image]]></description><pubDate>Thu, 20 Feb 2025 07:00:00 GMT</pubDate></item><item><title>Watch ContextVision’s CEO and CTO discuss the potential of Data Quality</title><link>https://news.cision.com/contextvision-ab/r/watch-contextvision-s-ceo-and-cto-discuss-the-potential-of-data-quality,c4105376</link><guid isPermaLink="false">cision4988858</guid><description><![CDATA[In an interview, CEO Gerald Pötzsch and CTO Gunnar Läthén discuss how ContextVision’s cutting-edge technology is set to revolutionize medical diagnostics and drive innovation through Data Quality.

Watch the interview here:
https://www.youtube.com/watch?v=JjRl47tnAHQ

For more information, please contact
Gerald Pötzsch
Chief Executive Officer, ContextVision
gerald.potzsch@contextvision.com

About ContextVision
ContextVision is a medical technology software company specialized in image analysis and artificial intelligence. As the global market leader within image enhancement, we]]></description><pubDate>Thu, 13 Feb 2025 12:30:00 GMT</pubDate></item><item><title>ContextVision and the University of Washington sign a partnership agreement to advance liver disease diagnosis</title><link>https://news.cision.com/contextvision-ab/r/contextvision-and-the-university-of-washington-sign-a-partnership-agreement-to-advance-liver-disease,c4099316</link><guid isPermaLink="false">cision4980658</guid><description><![CDATA[ContextVision announces the signing of a strategic clinical development partnership with the University of Washington School of Medicine in Seattle. The collaboration will focus on acquiring a medical imaging dataset to identify a multiparameter biomarker for screening and staging metabolic dysfunction-associated steatotic liver disease (MASLD). This marks an important step toward developing ContextVision’s new product line within data quality ultrasound.
ContextVision, a global market leader in medical imaging solutions, has partnered with the University of Washington, a top ten university]]></description><pubDate>Mon, 03 Feb 2025 07:00:00 GMT</pubDate></item><item><title>Correction: ContextVision AB: Result of the offer to buy back own shares</title><link>https://news.cision.com/contextvision-ab/r/correction--contextvision-ab--result-of-the-offer-to-buy-back-own-shares,c4084163</link><guid isPermaLink="false">cision4960061</guid><description><![CDATA[Stockholm, Dec 18, 2024

A correction is made to the press release published today, December 18, 2024, at 08.10 AM, regarding the number of shares resolved to be bought back by the company. A number of 35,722 shares were not included in the previous press release, the correct press release is as follows.

Reference is made to the stock exchange announcement on December 13th, 2024, in which ContextVision AB (publ) (“ContextVision” or the ”Company”) launched an offer to buy back up to 3,000,000 shares in the Company for a total amount of up to NOK 15,000,000 (the “Offer”).

The]]></description><pubDate>Wed, 18 Dec 2024 10:55:00 GMT</pubDate></item><item><title>ContextVision AB: Result of the offer to buy back own shares</title><link>https://news.cision.com/contextvision-ab/r/contextvision-ab--result-of-the-offer-to-buy-back-own-shares,c4083854</link><guid isPermaLink="false">cision4959749</guid><description><![CDATA[NOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY IN UNITED STATES, CANADA, AUSTRALIA, JAPAN OR ANY JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL OR WOULD REQUIRE REGISTRATION OR OTHER MEASURES.

Stockholm, Dec 18, 2024

Reference is made to the stock exchange announcement on December 13th, 2024, in which ContextVision AB (publ) (“ContextVision” or the ”Company”) launched an offer to buy back up to 3,000,000 shares in the Company for a total amount of up to NOK 15,000,000 (the “Offer”).

The application period for the Offer ended on December 17th, 2024 at]]></description><pubDate>Wed, 18 Dec 2024 07:10:00 GMT</pubDate></item><item><title>ContextVision AB: Launch of offer to buy back own shares</title><link>https://news.cision.com/contextvision-ab/r/contextvision-ab--launch-of-offer-to-buy-back-own-shares,c4081621</link><guid isPermaLink="false">cision4957003</guid><description><![CDATA[NOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY IN UNITED STATES, CANADA, AUSTRALIA, JAPAN OR ANY JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL OR WOULD REQUIRE REGISTRATION OR OTHER MEASURES.

Stockholm, Dec 13, 2024

ContextVision AB (publ) (“ContextVision” or the “Company”) hereby launches an offer to buy back up to 3,000,000 shares in the Company for an amount up to NOK 15,000,000 (the “Offer”). The purpose of the Offer is to acquire shares for use in connection with the Company’s Long-Term Incentive Program and/or to reduce the capital of the Company.]]></description><pubDate>Fri, 13 Dec 2024 07:30:00 GMT</pubDate></item><item><title>Mandatory notification of trade – primary insider</title><link>https://news.cision.com/contextvision-ab/r/mandatory-notification-of-trade---primary-insider,c4071247</link><guid isPermaLink="false">cision4945173</guid><description><![CDATA[Martin Hedlund, member of the Board of ContextVision has purchased shares in ContextVision.

With reference to Section 4-2 of the Norwegian Securities Trading Act (“STA”), kindly note the following primary insider share transactions:

Name of listed entity: ContextVision AB
ISIN number: SE0014731154
Stock ticker: CONTX
Name of primary insider: Martin Hedlund
Relation to listed entity: Member of the Board
Trade: 21.362 shares
Date: 21.11.2024
Average purchase price: NOK 4,99 per share
 

Name of listed entity: ContextVision AB
ISIN number: SE0014731154
Stock ticker: CONTX]]></description><pubDate>Mon, 25 Nov 2024 15:30:00 GMT</pubDate></item><item><title>Mandatory notification of trade – primary insider</title><link>https://news.cision.com/contextvision-ab/r/mandatory-notification-of-trade---primary-insider,c4070658</link><guid isPermaLink="false">cision4944361</guid><description><![CDATA[Gerald Pötzsch, CEO of ContextVision, and Olof Sandén, Chairman of the Board of ContextVision has purchased shares in ContextVision.
With reference to Section 4-2 of the Norwegian Securities Trading Act (“STA”), kindly note the following primary insider share transactions:

Name of listed entity: ContextVision AB
ISIN number: SE0014731154
Stock ticker: CONTX
Name of primary insider: Olof Sandén
Relation to listed entity: Chairman of the Board
Trade: 15.000 shares
Date: 08.11.2024
Average purchase price: NOK 4,83 per share
Primary insider’s total shareholdings post-purchase: 18.000]]></description><pubDate>Fri, 22 Nov 2024 15:31:00 GMT</pubDate></item><item><title>BULLETIN FROM THE EXTRAORDINARY GENERAL MEETING OF CONTEXTVISION AB (PUBL)</title><link>https://news.cision.com/contextvision-ab/r/bulletin-from-the-extraordinary-general-meeting-of-contextvision-ab--publ-,c4069073</link><guid isPermaLink="false">cision4942313</guid><description><![CDATA[At the Extraordinary General Meeting of ContextVision AB (publ) held on November 20, 2024, the following decisions were made:

authorization for the Board of Directors to resolve on the acquisition of the company's own shares

The General Meeting resolved in accordance with the Board of Directors’ proposal on an authorization for the Board of Directors to resolve on the acquisition of the company’s own shares. The acquisition may involve up to 3,000,000 shares in the company for an amount not exceeding NOK 15,000,000. The acquisition may only be made through a offer directed to all]]></description><pubDate>Wed, 20 Nov 2024 11:05:00 GMT</pubDate></item><item><title>Q3 interim report 2024 – Focus on internal efficiency and product development to drive long-term growth</title><link>https://news.cision.com/contextvision-ab/r/q3-interim-report-2024---focus-on-internal-efficiency-and-product-development-to-drive-long-term-gro,c4062339</link><guid isPermaLink="false">cision4933623</guid><description><![CDATA[Q3 Highlights

  · Continuing integration with newly signed customers in Asia and North America.
  · Close collaboration with the market to receive feedback from customers to strategically develop and enhance our products.
  · Internal reorganization to strenghen our teams and become more effective regarding marketing and product development.
  · Execution of roadmap for upcoming products.

Q3 Financial Data

  · Net Sales of 30.1 MSEK (32.8), down -8.1%.
  · Adjusted EBITDA amounted to 11.4 MSEK (14.5) with an adjusted EBITDA margin of 37.9% (44.2).*
  · Adjusted operating]]></description><pubDate>Thu, 07 Nov 2024 07:00:00 GMT</pubDate></item><item><title>ContextVision publishes Webcast for Q3 2024</title><link>https://news.cision.com/contextvision-ab/r/contextvision-publishes-webcast-for-q3-2024,c4062345</link><guid isPermaLink="false">cision4933625</guid><description><![CDATA[Watch CEO Gerald Pötzsch and CFO Richard Hallström present ContextVision’s highlights from Q3 2024 along the financials for the quarter.

The Webcast is available on ContextVision’s website following the link below:

https://www.contextvision.com/investors/webcast/

For more details, contact ContextVision’s CFO, Richard Hallström at richard.hallstrom@contextvision.com or visit our official website at www.contextvision.com.

About ContextVision
ContextVision is a medical technology software company specialized in image analysis and artificial intelligence. As the global market]]></description><pubDate>Thu, 07 Nov 2024 07:00:00 GMT</pubDate></item><item><title>Notice to the Extraordinary General Meeting in ContextVision AB (publ)</title><link>https://news.cision.com/contextvision-ab/r/notice-to-the-extraordinary-general-meeting-in-contextvision-ab--publ-,c4053547</link><guid isPermaLink="false">cision4920964</guid><description><![CDATA[The shareholders of ContextVision AB (publ), reg. no. 556377-8900, are hereby invited to the Extraordinary General Meeting on Wednesday, 20 November 2024, at 11:00, at the company's premises, Holländargatan 13, Stockholm.

Participation and Notification etc

Shareholders who wish to participate in the general meeting with the right to vote shall

  · be recorded as shareholder in the share register kept by Euroclear Sweden AB on Tuesday, 12 November 2024, temporary registration for shareholders registered at Norska Verdipapirsentralen (VPS) is made through DNB Bank ASA, see below; and]]></description><pubDate>Fri, 18 Oct 2024 15:00:00 GMT</pubDate></item><item><title>ContextVision publishes Webcast for Q2 2024</title><link>https://news.cision.com/contextvision-ab/r/contextvision-publishes-webcast-for-q2-2024,c4028329</link><guid isPermaLink="false">cision4886771</guid><description><![CDATA[Watch CEO Gerald Pötzsch and CFO Richard Hallström present ContextVision’s highlights from Q2 2024 along the financials for the quarter.

The Webcast is available on ContextVision’s website following the link below:

https://www.contextvision.com/investors/webcast/

For more details, contact ContextVision’s CFO, Richard Hallström at richard.hallstrom@contextvision.com or visit our official website at www.contextvision.com.

About ContextVision
ContextVision is a medical technology software company specialized in image analysis and artificial intelligence. As the global market]]></description><pubDate>Mon, 26 Aug 2024 06:00:00 GMT</pubDate></item><item><title>ContextVision AB: Q2 interim report 2024 - Strong cash position supports continued investment in Image and Data Quality</title><link>https://news.cision.com/contextvision-ab/r/contextvision-ab--q2-interim-report-2024---strong-cash-position-supports-continued-investment-in-ima,c4028132</link><guid isPermaLink="false">cision4886791</guid><description><![CDATA[Q2 Highlights

  · New customers signed in Asia and North America. ContextVision now has potential to expand its footprint in North America in different segments.
  · Stable cash flow and good cash position enable continued investments in image quality and in data quality.
  · Progress in Point-of-Care Ultrasound (POCUS) as ContextVision enters early stages of the development of new product pipeline for organ specific applications.
  · Final stage of signing an advanced development partnership regarding POCUS.

Q2 Financial Data

  · Net Sales of 31.7 MSEK (33.8), down -6.2%.
  ·]]></description><pubDate>Mon, 26 Aug 2024 06:00:00 GMT</pubDate></item></channel></rss>